Clinical trial

Three Fraction Radiation to Induce Immuno-Oncologic Response

NCT03978663

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2020-09-02

PhaseNA

Study timeline

Study start (actual)2020-09-02Date precision: day

Registry last updated2026-02-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

High-Risk Cancerunresolved

Locally Advanced Breast Cancerunresolved

Interventions

Neoadjuvant radiotherapyRADIATION

Sponsors & collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'slead sponsor

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03978663 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.